4YL3 | Crystal Structures of mPGES-1 Inhibitor Complexes | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Luz, J.G., Antonysamy, S., Kuklish, S.L., Fisher, M.J. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.41 | ||||||||||||
ligand | 4U9, BOG, GSH, PG4 | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics., Luz JG, Antonysamy S, Kuklish SL, Condon B, Lee MR, Allison D, Yu XP, Chandrasekhar S, Backer R, Zhang A, Russell M, Chang SS, Harvey A, Sloan AV, Fisher MJ, J Med Chem. 2015 May 20. PMID:25961169 |
Data retrieval |
View 4YL3 in 3D |
Visual 3D analysis of 4YL3 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4YL3 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |